JP2009504664A5 - - Google Patents

Download PDF

Info

Publication number
JP2009504664A5
JP2009504664A5 JP2008526175A JP2008526175A JP2009504664A5 JP 2009504664 A5 JP2009504664 A5 JP 2009504664A5 JP 2008526175 A JP2008526175 A JP 2008526175A JP 2008526175 A JP2008526175 A JP 2008526175A JP 2009504664 A5 JP2009504664 A5 JP 2009504664A5
Authority
JP
Japan
Prior art keywords
phenyl
benzyl
imidazol
amino
fluoro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008526175A
Other languages
English (en)
Japanese (ja)
Other versions
JP4975745B2 (ja
JP2009504664A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2006/031129 external-priority patent/WO2007021794A1/en
Publication of JP2009504664A publication Critical patent/JP2009504664A/ja
Publication of JP2009504664A5 publication Critical patent/JP2009504664A5/ja
Application granted granted Critical
Publication of JP4975745B2 publication Critical patent/JP4975745B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2008526175A 2005-08-09 2006-08-09 Kspインヒビターとしての置換イミダゾール化合物 Expired - Fee Related JP4975745B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US70690105P 2005-08-09 2005-08-09
US60/706,901 2005-08-09
PCT/US2006/031129 WO2007021794A1 (en) 2005-08-09 2006-08-09 Substituted imidazole compounds as ksp inhibitors

Publications (3)

Publication Number Publication Date
JP2009504664A JP2009504664A (ja) 2009-02-05
JP2009504664A5 true JP2009504664A5 (https=) 2012-02-23
JP4975745B2 JP4975745B2 (ja) 2012-07-11

Family

ID=37421032

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008526175A Expired - Fee Related JP4975745B2 (ja) 2005-08-09 2006-08-09 Kspインヒビターとしての置換イミダゾール化合物

Country Status (19)

Country Link
US (1) US7626040B2 (https=)
EP (1) EP1912972B1 (https=)
JP (1) JP4975745B2 (https=)
KR (1) KR20080036611A (https=)
CN (1) CN101253167A (https=)
AR (1) AR056025A1 (https=)
AT (1) ATE526324T1 (https=)
AU (1) AU2006279991B2 (https=)
BR (1) BRPI0614547A2 (https=)
CA (1) CA2618747A1 (https=)
ES (1) ES2374449T3 (https=)
GT (1) GT200600366A (https=)
MY (1) MY147188A (https=)
PE (1) PE20070352A1 (https=)
PL (1) PL1912972T3 (https=)
PT (1) PT1912972E (https=)
RU (1) RU2413721C9 (https=)
TW (1) TW200800951A (https=)
WO (1) WO2007021794A1 (https=)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2007323998B2 (en) * 2006-11-13 2011-09-22 Novartis Ag Substituted pyrazole and triazole compounds as KSP inhibitors
AU2008205169B2 (en) * 2007-01-05 2012-02-02 Novartis Ag Imidazole derivatives as kinesin spindle protein inhibitors (Eg-5)
AR068888A1 (es) 2007-10-19 2009-12-16 Schering Corp Derivados de 1, 3, 4 - tiadiazol, una composicion farmaceutica que los comprende y su uso en la preparacion de medicamentos para el tratamiento de enfermedades mediadas por la inhibicion de la quinesina ksp.
US8252832B2 (en) * 2007-12-14 2012-08-28 Novartis Ag Kinesin inhibitors as cancer therapeutics
JP2013523867A (ja) 2010-04-15 2013-06-17 ノバルティス アーゲー Ksp阻害剤としてのトリアゾール化合物
US9498540B2 (en) 2013-03-15 2016-11-22 Novartis Ag Cell proliferation inhibitors and conjugates thereof
EP2968591A1 (en) * 2013-03-15 2016-01-20 Novartis AG Cell proliferation inhibitors and conjugates thereof
PL3086814T3 (pl) * 2013-12-23 2020-12-28 Bayer Pharma Aktiengesellschaft Koniugaty środka wiążącego (ADC) z inhibitorami KSP
US10786578B2 (en) 2014-08-05 2020-09-29 Novartis Ag CKIT antibody drug conjugates
RU2751512C2 (ru) * 2015-06-22 2021-07-14 Байер Фарма Акциенгезельшафт Конъюгаты антитела и лекарственного средства (adc) и конъюгаты антитела и пролекарства (apdc), содержащие ферментативно расщепляемые группы
JP6768011B2 (ja) * 2015-06-23 2020-10-14 バイエル ファーマ アクチエンゲゼルシャフト キネシンスピンドルタンパク質(ksp)阻害剤の抗cd123抗体との抗体薬物複合体
WO2017216028A1 (en) 2016-06-15 2017-12-21 Bayer Pharma Aktiengesellschaft Specific antibody-drug-conjugates (adcs) with ksp inhibitors and anti-cd123-antibodies
JP7066714B2 (ja) 2016-12-21 2022-05-13 バイエル・ファルマ・アクティエンゲゼルシャフト 酵素的に切断可能な基を有する抗体薬物コンジュゲート(adc)
JP7030811B2 (ja) 2016-12-21 2022-03-07 バイエル・ファルマ・アクティエンゲゼルシャフト Ksp阻害剤を有する特異的抗体-薬物コンジュゲート(adc)
JP2021527640A (ja) 2018-06-18 2021-10-14 バイエル アクチェンゲゼルシャフトBayer Aktiengesellschaft 酵素的に切断可能なリンカーおよび改善された活性プロファイルを有する、cxcr5に対して向けられるバインダー/活性薬剤複合体
CN109481436A (zh) * 2018-08-21 2019-03-19 广东医科大学 血栓素a2合成酶抑制剂奥扎格雷在制备治疗吸烟所致肺癌药物中的应用

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4235871A (en) 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
US4501728A (en) 1983-01-06 1985-02-26 Technology Unlimited, Inc. Masking of liposomes from RES recognition
US4837028A (en) 1986-12-24 1989-06-06 Liposome Technology, Inc. Liposomes with enhanced circulation time
US5011472A (en) 1988-09-06 1991-04-30 Brown University Research Foundation Implantable delivery system for biological factors
EP0946587A2 (en) 1996-12-16 1999-10-06 Fujisawa Pharmaceutical Co., Ltd. New amide compounds
US6117940A (en) 1997-10-17 2000-09-12 Mjalli; Adnan M. M. Amino-ketone solid support templates
US6852725B1 (en) * 1998-06-12 2005-02-08 Societe De Conseils De Recherches Et D'applications Scientifiques, S. A. S. Imidazolyl derivatives
ATE327224T1 (de) * 1999-10-27 2006-06-15 Cytokinetics Inc Chinazolinone benutzende verfahren und zusammenstellungen
US6545004B1 (en) * 1999-10-27 2003-04-08 Cytokinetics, Inc. Methods and compositions utilizing quinazolinones
US6620882B1 (en) 2000-05-02 2003-09-16 Advanced Syntech, Llc Solid support template for preparation of highly functionalized heterocycle compounds
WO2002010140A2 (en) * 2000-08-01 2002-02-07 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) Imidazolyl derivatives
US7026312B2 (en) * 2002-03-14 2006-04-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Substituted piperidines, pharmaceutical compositions containing these compounds, their use and processes for the preparation thereof
DE10211770A1 (de) 2002-03-14 2003-10-02 Boehringer Ingelheim Pharma Neue substituierte Piperidine, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
RU2005100783A (ru) * 2002-06-14 2005-07-20 Мерк энд Ко., Инк. (US) Ингибиторы митотического кинезина
WO2004071448A2 (en) 2003-02-12 2004-08-26 Transtech Pharma Inc. Substituted azole derivatives as inhibitors of protein tyrosine phosphatases
EP1620092A4 (en) * 2003-05-07 2008-04-16 Cytokinetics Inc COMPOUNDS, COMPOSITIONS AND METHODS
EP1622878A4 (en) * 2003-05-15 2008-04-09 Cytokinetics Inc COMPOUNDS, COMPOSITIONS AND METHODS
WO2005100322A1 (en) 2004-04-14 2005-10-27 Pfizer Limited Sulphur-linked imidazole compounds for the treament of hiv
US7618981B2 (en) 2004-05-06 2009-11-17 Cytokinetics, Inc. Imidazopyridinyl-benzamide anti-cancer agents
KR101170925B1 (ko) * 2004-06-18 2012-08-07 노바티스 백신즈 앤드 다이아그노스틱스 인코포레이티드 암 치료용 키네신 방추 단백질 (ksp) 억제제로서의n-(1-(1-벤질-4-페닐-1h-이미다졸-2-일)-2,2-디메틸프로필)벤자미드 유도체 및 관련 화합물

Similar Documents

Publication Publication Date Title
JP2009504664A5 (https=)
RU2375352C2 (ru) Амидные производные
JP2025016684A5 (https=)
RU2427572C2 (ru) N-(1-(1-бензил-4-фенил-1н-имидазол-2-ил)-2,2-диметилпропил)бензамидные производные и родственные соединения в качестве ингибиторов кинезинового белка веретена (ksp) для лечения рака
RU2008108939A (ru) Замещенные имидазолы, фармацевтическая композиция, способ лечения заболевания, связанного по крайней мере с активностью ksp, способ ингибирования ksp, лекарственное средство для лечения рака
KR101985050B1 (ko) 피라진카르복사미드 화합물
IL295799A (en) Trophomyosin receptor kinase (trk) degradation compounds and methods of use
RU2433128C2 (ru) Новые пиримидиновые производные и их применение в терапии, а также применение пиримидиновых производных в изготовлении лекарственного средства для предупреждения и/или лечения болезни альцгеймера
KR102510858B1 (ko) 알파 v 인테그린 억제제로서의 아졸 아미드 및 아민
JP2008503501A5 (https=)
JP2019517596A5 (https=)
JPWO2021087025A5 (https=)
JP2016536333A5 (https=)
RU2003127116A (ru) Гетероциклические ингибиторы erk2 и их использование
JP2008528467A5 (https=)
HRP20140737T1 (hr) Inhibitori hepatitis c virusa
CN101605540A (zh) 使用mek抑制剂的方法
JP2011526616A (ja) 化学化合物
RU2005130486A (ru) Хиназолины, полезные в качестве модуляторов ионных каналов
JP2012528166A5 (https=)
US20210261542A1 (en) Compounds which inhibit rna polymerase, compositions including such compounds, and their use
JP2004517840A (ja) フェニルアセトアミド−ピラゾール誘導体およびそれの抗腫瘍薬としての使用
JP2009513575A5 (https=)
RU2006145205A (ru) Терапевтические соединения: пиридин в качестве каркаса
CA2989469A1 (en) 3-amino-1,5,6,7-tetrahydro-4h-indol-4-ones